Truvada For HIV Prevention Plus Behavioral Strategies
A drug that has been shown to prevent HIV infection in a significant number of cases must be combined with behavioral approaches if the U.S. health care establishment is to succeed in reducing the spread of the virus, according to the American Psychological Association. "Exclusive reliance on a drug to ...
HIV Prevention Pill Receives FDA Panel Support
On Thursday, a panel of outside experts that advises the US Food and Drug Administration (FDA) voted to support approval of the daily pill Truvada to prevent HIV in healthy people. The FDA is not obliged to follow the advice of its Antiviral Drugs Advisory Committee, but ...
Preventing Spread Of HIV And TB In African Prisons
In order to reduce HIV and TB in African prisons, African governments and international health donors should fund criminal justice reforms, experts from Human Rights Watch say in this week's PLoS Medicine...
Women In Resource-Poor Countries Can Flash-Heat Breast Milk To Inactivate HIV
An international team led by UC Davis researchers has found that mothers in sub-Saharan Africa could successfully follow a protocol for flash-heating breast milk to reduce transmission of human immunodeficiency virus (HIV) -- the virus that causes AIDS -- to their infants. Flash-heating breast milk is recommended by the World ...
Compliance By African-Americans To HIV Therapy Problematic, Untreated Depression Makes It Worse
African-Americans with HIV are much less likely to adhere to drug therapy than others with the disease, according to a University of Michigan study. Moreover, untreated depression may greatly hinder adherence to antiretroviral therapy (ART) for all low-income, HIV-infected patients, regardless of race. The study is the first known to ...
Cell Therapy Shows Promise In Fight Against HIV
UC Davis Health System researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that causes AIDS. In a paper published in the May issue of the Journal of Virology, the UC Davis HIV team demonstrated both ...
Decade-Long Study Of HIV Patients Finds Gene Therapy Safe, Lasting
HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Translational Medicine. The results provide a framework for the use of this type of ...